We are live on ! Find out more
KM

Kalos Management Portfolio holdings

AUM $46.6M
1-Year Est. Return 11.52%
This Fund
S&P 500
This Quarter Est. Return
-18.04%
1 Year Est. Return
+11.52%
3 Year Est. Return
+48.48%
5 Year Est. Return
+71.6%
10 Year Est. Return
AUM
$224M
AUM Growth
-$50.1M
Cap. Flow
+$6.27M
Cap. Flow %
2.79%
Top 10 Hldgs %
26.95%
Holding
263
New
60
Increased
65
Reduced
68
Closed
59

Sector Composition

Rank Sector Weight
1 Technology 11.29%
2 Financials 7.16%
3 Communication Services 6.93%
4 Healthcare 6.78%
5 Consumer Discretionary 5.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARCC icon
176
Ares Capital
ARCC
$13.5B
$129K 0.06%
+12,049
New +$203K
CLVS
177
DELISTED
Clovis Oncology, Inc.
CLVS
$119K 0.05%
18,550
+7,500
+68% +$60.2K
APTS
178
DELISTED
Preferred Apartment Communities, Inc.
APTS
$111K 0.05%
+15,527
New +$168K
KGC icon
179
Kinross Gold
KGC
$27.4B
$110K 0.05%
+16,460
New +$79.6K
CTSO icon
180
Cytosorbents Corp
CTSO
$22.7M
$104K 0.05%
13,500
NLY icon
181
Annaly Capital Management
NLY
$17.1B
$98K 0.04%
+4,209
New +$148K
FOLD
182
DELISTED
Amicus Therapeutics
FOLD
$93K 0.04%
10,150
GYRE icon
183
Gyre Therapeutics
GYRE
$641M
$86K 0.04%
2,575
+134
+5% +$6.16K
PRTK
184
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$78K 0.03%
25,050
VSTM icon
185
Verastem
VSTM
$510M
$77K 0.03%
2,438
AMRN
186
Amarin Corp
AMRN
$299M
$61K 0.03%
738
-135
-15% -$44.9K
PSLV icon
187
Sprott Physical Silver Trust
PSLV
$12B
$59K 0.03%
11,342
-1,025
-8% -$6.31K
QEP
188
DELISTED
QEP RESOURCES, INC.
QEP
$58K 0.03%
68,500
-186,206
-73% -$448K
AGRX
189
DELISTED
Agile Therapeutics
AGRX
$42K 0.02%
+11
New +$63.1K
BCRX icon
190
BioCryst Pharmaceuticals
BCRX
$2.28B
$37K 0.02%
+18,950
New +$52.2K
HTGM
191
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$24K 0.01%
405
+33
+9% +$3.23K
HSTO
192
DELISTED
Histogen Inc. Common Stock
HSTO
$13K 0.01%
220
+12
+6% +$937
SNMP
193
DELISTED
Evolve Transition Infrastructure LP
SNMP
$9K ﹤0.01%
+721
New +$8.07K
PFX icon
194
PhenixFIN
PFX
$7K ﹤0.01%
675
ACWV icon
195
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.32B
-3,129
Closed -$310K
AXP icon
196
American Express
AXP
$227B
-2,095
Closed -$260K
BNY
197
Bank of New York Mellon
BNY
$106B
-7,659
Closed -$385K
BSX icon
198
Boston Scientific
BSX
$69.5B
-43,327
Closed -$1.96M
C icon
199
Citigroup
C
$222B
-32,300
Closed -$2.58M
CDW icon
200
CDW
CDW
$18.9B
-2,124
Closed -$303K

Similar funds

Kalos Management's Q1 2020 Portfolio in Review

As of Q1 2020, Kalos Management held 263 positions worth $224M, down 18% from $274M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Kalos Management's Q1 2020 filing shows 60 new, 65 increased, 68 reduced and 59 closed positions. Its largest new stake was Delta Air Lines: 98,881 shares worth $2.18M. The largest sale was iShares S&P 500 Growth ETF, an estimated $7.49M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Communication Services.

  • Kalos Management's largest Q1 2020 buy was Delta Air Lines: 98,881 shares worth $2.18M.
  • Kalos Management added most to McDonald's in Q1 2020, an estimated $12.4M increase.
  • Kalos Management's biggest Q1 2020 reduction was iShares S&P 500 Growth ETF, cutting an estimated $7.49M.
  • Kalos Management fully exited State Street SPDR Dow Jones Industrial Average ETF Trust in Q1 2020, selling an estimated $4.99M.
  • Kalos Management's ten largest holdings make up 27% of its $224M portfolio in Q1 2020.
  • Kalos Management opened 60 new positions and closed 59 in Q1 2020.
  • Kalos Management's portfolio value fell 18% quarter-over-quarter to $224M.

Based on Kalos Management's 13F filing for Q1 2020, filed 13 May 2020.